comparemela.com

Latest Breaking News On - Optiva securities - Page 10 : comparemela.com

OKYO Pharma (OKYO) Prices $5 74M Private Placement

OKYO Pharma (OKYO) Prices $5 74M Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofJohn brancaccioGabriele cerroneRaj patilGarys jacobWilly simonPaul spencerRobert emmetKeeren shahPharma limited nasdaqInternational financial reporting standardsLondon stock exchangePharma limitedFinancial servicesExchange commission

OKYO Pharma LTD: OKYO Pharma Limited announces U S $5 74 million Global Private Placement and investment by directors and members of senior management

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER

United statesUnited kingdomCity ofDennis riedlJohn brancaccioGabriele cerroneRaj patilGarys jacobWilly simonPaul spencerRobert emmetKeeren shahPharma limited nasdaqInternational financial reporting standardsLondon stock exchangePharma limited

Investegate |Beacon Energy PLC Announcements | Beacon Energy PLC: Publication of Pathfinder Admission Document

Investegate announcements from Beacon Energy PLC, Publication of Pathfinder Admission Document

United kingdomChristian dennisRory murphy james bellmanPeter krens ed haig thomasBen romney jon krinksLarry bottomleyBeacon energyShard capital partnersOptiva securities limited joint brokerCompany nominated adviserFinancial conduct authorityRhein petroleumUnited statesStrand hanson limited financialEuropean union withdrawalCompany admission document

OKYO Pharma LTD: OKYO Pharma Announces Appointment of Dr Jay S Pepose to Its Scientific Advisory Board

World-renowned Ophthalmologist with Expertise in the Medical and Surgical Treatment of Ocular Surface Diseases Joins Advisory Board of OKYO PharmaLONDON and NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE)

City ofUnited kingdomDennis riedlRobert emmetPaul spencerGarys jacobJays peposeSchool of medicinePharma limitedBrandeis universityGeorgetown university medical centerJohns hopkins medical centerPepose vision instituteOptiva securitiesWilmer instituteWorld renowned ophthalmologist

OKYO Pharma LTD: OKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023

LONDON and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) ("OKYO", "OKYO Pharma" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which

United statesUnited kingdomCity ofDennis riedlRobert emmetPaul spencerAlan kopinGarys jacobLondon stock exchangePharma limitedDrug administrationOptiva securitiesNovel therapeuticTargeted drug discovery summitHyatt regencyChief scientific officer

vimarsana © 2020. All Rights Reserved.